|CAS No.: 10236-47-2||Request for quotation|
Naringin, a flavanone glycoside antioxidant, was reported to have antidiabetic and anti-apoptotic properties. Experiment result shows that angiogenesis was improved via naringin-mediated inhibition of hyperglycemia, oxidative stress, down-regulation of inflammatory mediator expression and up-regulation of growth factor expression, leading to improved wound healing of DFU.
Naringin improved wound area, glycated Hb, serum glucose level and insulin.
|Appearance||Off-White powder||Standard Packing||500g/bag or per customer request|
|Loss on drying||≤ 5%||Inventory||Normally we have Naringin in stock|
|Residue on ignition||≤ 5 %|
|Heavy metals||≤ 10 ppm||Naringin physical parameters|
|Residual Solvent||≤ 0.05%||CAS No:||10236-47-2|
|As||≤ 5 ppm||Formula||C27H33O14|
|Assay||≥ 98%||Molecular Weight||580.53|
|Total plate count||≤ 1000 cfu/g||Synonym||4',5,7-Trihydroxyflavanone 7-rhamnoglucoside, Naringenine-7-rhamnosidoglucoside|
|Yeast & Mold||≤ 100 cfu/g||Structure|
|Certificate of Analysis||Naringin COA|
|1.||Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. DOI: 10.1016/j.cbi.2014.05.012|
Copyright © 2014. All Rights Reserved.